MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy-Reference-Cited by-同舟云学术

MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy

Published:2013-04-24 Issue:5 Volume:123 Page:2143-2154
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Halkein Julie,Tabruyn Sebastien P.,Ricke-Hoch Melanie,Haghikia Arash,Nguyen Ngoc-Quynh-Nhu,Scherr Michaela,Castermans Karolien,Malvaux Ludovic,Lambert Vincent,Thiry Marc,Sliwa Karen,Noel Agnes,Martial Joseph A.,Hilfiker-Kleiner Denise,Struman Ingrid

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference47 articles.

1. Peripartum Cardiomyopathy: Recent Insights in its Pathophysiology

2. A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy

3. Recovery From Postpartum Cardiomyopathy in 2 Patients by Blocking Prolactin Release With Bromocriptine

4. Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum Cardiomyopathy

5. Molecular Targeting of Antiangiogenic Factor 16K hPRL Inhibits Oxygen-Induced Retinopathy in Mice

Cited by 417 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insight into endothelial cell-derived extracellular vesicles in cardiovascular disease: Molecular mechanisms and clinical implications;Pharmacological Research;2024-09

2. Diagnosis and management of peripartum cardiomyopathy and recurrence risk;International Journal of Cardiology Congenital Heart Disease;2024-09

3. Stem cell and exosome therapies for regenerating damaged myocardium in heart failure;Life Sciences;2024-08

4. New uses of halofuginone to treat cancer;Journal of Pharmaceutical Analysis;2024-08

5. Engineered exosomes: a potential therapeutic strategy for septic cardiomyopathy;Frontiers in Cardiovascular Medicine;2024-06-28